GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,963,000 | +358.7% | 91,027 | +359.2% | 0.00% | – |
| Q1 2022 | $864,000 | -0.1% | 19,822 | +1.0% | 0.00% | – |
| Q4 2021 | $865,000 | +10.8% | 19,622 | -4.2% | 0.00% | – |
| Q3 2021 | $781,000 | -5.9% | 20,472 | -1.7% | 0.00% | – |
| Q2 2021 | $830,000 | -78.5% | 20,822 | -80.7% | 0.00% | -100.0% |
| Q1 2021 | $3,854,000 | +389.1% | 107,983 | +404.8% | 0.00% | – |
| Q4 2020 | $788,000 | -74.3% | 21,393 | -73.8% | 0.00% | -100.0% |
| Q3 2020 | $3,069,000 | -23.8% | 81,529 | -17.5% | 0.00% | -33.3% |
| Q2 2020 | $4,030,000 | -4.2% | 98,771 | -11.0% | 0.00% | -25.0% |
| Q1 2020 | $4,205,000 | -12.6% | 110,999 | +8.3% | 0.00% | +33.3% |
| Q4 2019 | $4,813,000 | -85.3% | 102,499 | -86.6% | 0.00% | -87.0% |
| Q3 2019 | $32,744,000 | -61.6% | 767,285 | -64.0% | 0.02% | -54.0% |
| Q2 2019 | $85,297,000 | +52.9% | 2,131,401 | +59.7% | 0.05% | +51.5% |
| Q1 2019 | $55,772,000 | +175.8% | 1,334,689 | +152.2% | 0.03% | +135.7% |
| Q4 2018 | $20,222,000 | +18.7% | 529,309 | +24.7% | 0.01% | +180.0% |
| Q3 2018 | $17,043,000 | -89.5% | 424,352 | -89.5% | 0.01% | -89.1% |
| Q2 2018 | $162,971,000 | +1917.5% | 4,043,031 | +1854.2% | 0.05% | +1050.0% |
| Q1 2018 | $8,078,000 | +106.7% | 206,888 | +87.6% | 0.00% | +33.3% |
| Q4 2017 | $3,909,000 | -24.8% | 110,295 | -13.9% | 0.00% | -25.0% |
| Q3 2017 | $5,197,000 | -80.7% | 128,134 | -79.5% | 0.00% | -78.9% |
| Q2 2017 | $26,972,000 | +197.0% | 625,616 | +190.3% | 0.02% | +171.4% |
| Q1 2017 | $9,080,000 | -46.7% | 215,480 | -51.3% | 0.01% | -50.0% |
| Q4 2016 | $17,023,000 | +34.7% | 442,177 | +50.9% | 0.01% | +55.6% |
| Q3 2016 | $12,637,000 | -33.9% | 293,110 | -33.6% | 0.01% | -35.7% |
| Q2 2016 | $19,125,000 | +6.0% | 441,404 | -0.8% | 0.01% | 0.0% |
| Q1 2016 | $18,043,000 | -0.9% | 445,095 | -1.4% | 0.01% | +7.7% |
| Q4 2015 | $18,201,000 | +14.1% | 451,206 | +8.7% | 0.01% | +8.3% |
| Q3 2015 | $15,952,000 | -52.3% | 415,042 | -48.3% | 0.01% | -42.9% |
| Q2 2015 | $33,462,000 | +56.0% | 803,536 | +72.8% | 0.02% | +61.5% |
| Q1 2015 | $21,450,000 | +81.2% | 464,902 | +67.8% | 0.01% | +85.7% |
| Q4 2014 | $11,836,000 | -57.5% | 277,020 | -54.2% | 0.01% | -58.8% |
| Q3 2014 | $27,827,000 | -22.6% | 605,388 | -10.0% | 0.02% | -29.2% |
| Q2 2014 | $35,971,000 | +59.7% | 672,679 | +59.6% | 0.02% | +50.0% |
| Q1 2014 | $22,521,000 | +193.0% | 421,590 | +192.8% | 0.02% | +166.7% |
| Q4 2013 | $7,686,000 | -40.1% | 143,999 | -43.7% | 0.01% | -33.3% |
| Q3 2013 | $12,821,000 | – | 255,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |